Stay updated on Pembrolizumab in MPM Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in MPM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in MPM Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces updates and FAQs about agencies adopting “Super Intelligence” in place of “Artificial Intelligence” during a transition.
    Difference
    1%
    Check dated 2026-10-26T16:46:48.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.1 to v3.7.2 while the page continued to show a 403 error.
    Difference
    0.2%
    Check dated 2026-10-19T21:52:01.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision label changed from v3.7.0 to v3.7.1. The page still displays a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-13T04:44:58.000Z thumbnail image
  4. Check
    38 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error, replacing the previous study content. This indicates the record is temporarily unavailable or access is restricted, preventing viewing the trial details.
    Difference
    19%
    Check dated 2026-09-21T22:41:04.000Z thumbnail image
  5. Check
    59 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.5 to v3.6.6, indicating a minor release update to the page.
    Difference
    0.0%
    Check dated 2026-08-31T17:00:30.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    The study's official identifiers now include a funding attribution: 2016 ( U.S. NIH Grant/Contract ). This adds NIH funding as part of the study's identifiers.
    Difference
    0.0%
    Check dated 2026-08-24T17:08:43.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in MPM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in MPM Clinical Trial page.